ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

KRTX Karuna Therapeutics Inc

329.83
0.00 (0.00%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Karuna Therapeutics Inc KRTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 329.83 09:00:00
개장가 저가 고가 종가 전일 종가
329.83 329.83
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
12/03/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202407:01EDGAR2Form 144 - Report of proposed sale of securities
01/03/202420:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/03/202420:01EDGAR2Form 8-K - Current report
22/02/202420:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/02/202420:32EDGAR2Form 8-K - Current report
22/02/202420:30BWKaruna Therapeutics Reports Fourth Quarter and Full Year..
16/02/202406:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202406:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202400:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/02/202407:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202407:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202401:56EDGAR2Form 144 - Report of proposed sale of securities
06/02/202406:12EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
22/01/202420:05EDGAR2Form PREM14A - Preliminary proxy statements relating to..
17/01/202406:18EDGAR2Form 8-K - Current report
10/01/202406:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202406:18EDGAR2Form 144 - Report of proposed sale of securities
09/01/202400:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
30/12/202306:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202307:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202307:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202307:07EDGAR2Form 8-K - Current report
23/12/202306:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202306:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202306:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202305:30PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
23/12/202301:15DJNTrending: Bristol Myers to Buy Karuna Therapeutics for $14..
22/12/202322:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202322:26EDGAR2Form 8-K - Current report
22/12/202321:05BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
22/12/202320:59BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
15/12/202308:30BWKaruna Therapeutics Announces The Lancet Publication of Data..
13/12/202306:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202305:24EDGAR2Form 144 - Report of proposed sale of securities
30/11/202300:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
29/11/202321:13DJNKaruna Therapeutics Gets FDA Acceptance for KarXT NDA
29/11/202320:30BWKaruna Therapeutics Announces U.S. Food and Drug..
17/11/202306:01BWKaruna Therapeutics Announces Positive Results from Phase 1b..
14/11/202307:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202306:25EDGAR2Form 144 - Report of proposed sale of securities
02/11/202319:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202319:36EDGAR2Form 8-K - Current report
02/11/202319:30BWKaruna Therapeutics Reports Third Quarter 2023 Financial..
01/11/202319:45BWKaruna Therapeutics to Present Data from the EMERGENT..
01/11/202319:30BWKaruna Therapeutics to Present at Upcoming Investor..
19/10/202319:30BWKaruna Therapeutics to Announce Third Quarter 2023 Financial..
11/10/202305:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

Delayed Upgrade Clock